Danaher Co. (NYSE:DHR) Shares Sold by Concentric Capital Strategies LP

Concentric Capital Strategies LP cut its holdings in Danaher Co. (NYSE:DHR - Free Report) by 80.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,392 shares of the conglomerate's stock after selling 5,790 shares during the quarter. Concentric Capital Strategies LP's holdings in Danaher were worth $320,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Consulta Ltd raised its stake in shares of Danaher by 20.0% in the fourth quarter. Consulta Ltd now owns 600,000 shares of the conglomerate's stock valued at $137,730,000 after acquiring an additional 100,000 shares during the period. Cetera Investment Advisers raised its stake in shares of Danaher by 0.9% in the fourth quarter. Cetera Investment Advisers now owns 134,273 shares of the conglomerate's stock valued at $30,822,000 after acquiring an additional 1,189 shares during the period. BOKF NA raised its stake in shares of Danaher by 2.5% in the fourth quarter. BOKF NA now owns 46,329 shares of the conglomerate's stock valued at $10,891,000 after acquiring an additional 1,124 shares during the period. BlueSpruce Investments LP raised its stake in shares of Danaher by 23,418.4% in the fourth quarter. BlueSpruce Investments LP now owns 496,004 shares of the conglomerate's stock valued at $113,858,000 after acquiring an additional 493,895 shares during the period. Finally, Bridgefront Capital LLC purchased a new stake in shares of Danaher during the fourth quarter valued at $698,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DHR. Jefferies Financial Group lowered their target price on shares of Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research note on Tuesday, April 22nd. UBS Group lowered their target price on shares of Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group decreased their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Robert W. Baird dropped their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup reiterated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $264.40.

Insider Transactions at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company's stock.

Danaher Trading Down 2.8%

NYSE DHR traded down $5.40 during trading hours on Friday, reaching $189.42. The company had a trading volume of 4,535,806 shares, compared to its average volume of 3,411,207. The stock has a 50-day moving average of $198.39 and a 200 day moving average of $219.00. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $135.56 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. As a group, research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.68%. Danaher's dividend payout ratio is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.